Author: Matt Jonsen

Matt's practice focuses on emerging biotechnology and pharmaceutical companies.

IP of Pot Part I: Introduction

A fog of uncertainty surrounds regulations in the marijuana industry. At the federal level, the plant is still a Schedule 1 substance under the Controlled Substances Act and, therefore, federally illegal to possess, sell,...